Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Work In Process (2016)

Historic Work In Process for NovaBay Pharmaceuticals (NBY) over the last 3 years, with Q2 2016 value amounting to $27000.0.

  • NovaBay Pharmaceuticals' Work In Process fell 8532.61% to $27000.0 in Q2 2016 from the same period last year, while for Jun 2016 it was $27000.0, marking a year-over-year decrease of 8532.61%. This contributed to the annual value of $248000.0 for FY2015, which is 3478.26% up from last year.
  • As of Q2 2016, NovaBay Pharmaceuticals' Work In Process stood at $27000.0, which was down 8532.61% from $114000.0 recorded in Q1 2016.
  • NovaBay Pharmaceuticals' Work In Process' 5-year high stood at $248000.0 during Q4 2015, with a 5-year trough of $27000.0 in Q2 2016.
  • Over the past 3 years, NovaBay Pharmaceuticals' median Work In Process value was $184000.0 (recorded in 2014), while the average stood at $165285.7.
  • Its Work In Process has fluctuated over the past 5 years, first soared by 3478.26% in 2015, then crashed by 8532.61% in 2016.
  • Over the past 3 years, NovaBay Pharmaceuticals' Work In Process (Quarter) stood at $184000.0 in 2014, then soared by 34.78% to $248000.0 in 2015, then crashed by 89.11% to $27000.0 in 2016.
  • Its Work In Process stands at $27000.0 for Q2 2016, versus $114000.0 for Q1 2016 and $248000.0 for Q4 2015.